Additionally, three ICRGs (ADORA2A, CD226, and CD40) showed differently significant correlation with five SWDEGs in both diseases, which provided further insights into potential biological interactions and immune regulatory mechanisms underlying NASH and IBD. This evidence concerns the gene CD226 and metabolic dysfunction-associated steatohepatitis.